EditorialIntracoronary function testing in patients with INOCA: Is it worth the money?
References (17)
- et al.
Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease
J. Am. Coll. Cardiol.
(2019) - et al.
Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm
Int. J. Cardiol.
(2021) - et al.
Long-term follow-up in patients with stable angina and unobstructed coronary arteries undergoing intracoronary acetylcholine testing
JACC Cardiovasc. Interv.
(2020) - et al.
Impact of abnormal coronary reactivity on long-term clinical outcomes in women
J. Am. Coll. Cardiol.
(2019) - et al.
Functional and economic impact of INOCA and influence of coronary microvascular dysfunction
JACC Cardiovasc. Imaging
(2021) - et al.
1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)
JACC Cardiovasc. Interv.
(2020) - et al.
Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial
J. Am. Coll. Cardiol.
(2018) - et al.
Low diagnostic yield of elective coronary angiography
N. Engl. J. Med.
(2010)
There are more references available in the full text version of this article.
Cited by (0)
© 2021 Elsevier B.V. All rights reserved.